TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan · Delayed Price · Currency is TWD 6.78
-0.10 (-1.45%)
Sep 11, 2026, 2:05 PM CST
TaiwanJ Pharmaceuticals Market Cap
TaiwanJ Pharmaceuticals has a market cap or net worth of 551.24 million as of September 11, 2026. Its market cap has decreased by -20.74% in one year.
Market Cap
551.24M
Enterprise Value
493.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.78
ChartMarket Cap Chart
Since October 21, 2015, TaiwanJ Pharmaceuticals's market cap has decreased from 2.26B to 551.24M, a decrease of -75.57%. That is a compound annual growth rate of -12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 551.24M | -10.77% |
| Dec 31, 2025 | 617.74M | -5.98% |
| Dec 31, 2024 | 657.00M | -40.71% |
| Dec 29, 2023 | 1.11B | 39.15% |
| Dec 30, 2022 | 796.29M | 4.93% |
| Dec 30, 2021 | 758.89M | -24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 854.19M |
| Neith | 793.51M |
| Lukas Biomedical | 732.80M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 698.99M |
| SynCore Biotechnology Co.,Ltd | 664.62M |
| Taiwan Advance Bio-Pharmaceutical | 645.30M |
| LAUNXP Biomedical | 584.19M |